HEADER SIGNALING PROTEIN 13-JUL-23 8PSW TITLE ERK2 COVALENTLY BOUND TO RU67 CYCLOHEXENONE BASED INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE 1,MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED COMPND 5 KINASE 2,ERK-2,MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED COMPND 6 PROTEIN KINASE 2,MAP KINASE 2,MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: THE DEPHOSPHORYLATED INACTIVE ERK2 KINASE WITH RU67 COMPND 10 COVALENT INHIBITOR AT THE DOCKING GROOVE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS MAPK KINASE, MAPK, INHIBITOR, COVALENT, ERK2, MICHAEL ACCEPTOR KEYWDS 2 WARHEAD, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.SOK,A.POTI,A.REMENYI,G.GOGL REVDAT 1 24-JUL-24 8PSW 0 JRNL AUTH P.SOK,A.POTI,A.REMENYI,T.SOOS,D.BALINT JRNL TITL TARGETING A KEY PROTEIN-PROTEIN INTERACTION SURFACE ON JRNL TITL 2 MITOGEN-ACTIVATED PROTEIN KINASES BY A MICHAEL JRNL TITL 3 ACCEPTOR-BASED CYCLIC WARHEAD SCAFFOLD JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.14 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 28468 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1440 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 4.3100 - 3.4200 1.00 2766 125 0.1626 0.1683 REMARK 3 2 3.4200 - 2.9900 1.00 2698 152 0.1785 0.1940 REMARK 3 3 2.9900 - 2.7100 1.00 2698 148 0.1969 0.2737 REMARK 3 4 2.7100 - 2.5200 1.00 2704 129 0.2145 0.2248 REMARK 3 5 2.5200 - 2.3700 1.00 2673 142 0.2147 0.2550 REMARK 3 6 2.3700 - 2.2500 1.00 2668 140 0.2264 0.2921 REMARK 3 7 2.2500 - 2.1500 1.00 2655 136 0.2309 0.2443 REMARK 3 8 2.1500 - 2.0700 1.00 2648 152 0.2451 0.2910 REMARK 3 9 2.0700 - 2.0000 1.00 2630 153 0.2955 0.3390 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.720 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 11 THROUGH 162 ) REMARK 3 ORIGIN FOR THE GROUP (A): -17.7255 -13.8208 11.9626 REMARK 3 T TENSOR REMARK 3 T11: 0.1522 T22: 0.2316 REMARK 3 T33: 0.2744 T12: -0.0145 REMARK 3 T13: 0.0058 T23: -0.0199 REMARK 3 L TENSOR REMARK 3 L11: 1.3472 L22: 1.7227 REMARK 3 L33: 3.7591 L12: -0.1577 REMARK 3 L13: -0.2762 L23: 0.9559 REMARK 3 S TENSOR REMARK 3 S11: 0.0412 S12: 0.0731 S13: 0.0342 REMARK 3 S21: 0.1490 S22: -0.0747 S23: 0.0886 REMARK 3 S31: -0.0046 S32: -0.1418 S33: 0.0151 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 163 THROUGH 223 ) REMARK 3 ORIGIN FOR THE GROUP (A): -14.7121 -8.6217 29.4650 REMARK 3 T TENSOR REMARK 3 T11: 0.3956 T22: 0.2811 REMARK 3 T33: 0.2919 T12: -0.0420 REMARK 3 T13: -0.0388 T23: -0.0059 REMARK 3 L TENSOR REMARK 3 L11: 2.1798 L22: 5.5818 REMARK 3 L33: 7.5634 L12: -0.7177 REMARK 3 L13: -1.6297 L23: 2.1534 REMARK 3 S TENSOR REMARK 3 S11: 0.0345 S12: -0.1679 S13: 0.3392 REMARK 3 S21: 0.4770 S22: 0.1054 S23: -0.0578 REMARK 3 S31: -0.3522 S32: 0.4707 S33: -0.0996 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 224 THROUGH 326 ) REMARK 3 ORIGIN FOR THE GROUP (A): -14.5164 -13.0474 40.2810 REMARK 3 T TENSOR REMARK 3 T11: 0.6710 T22: 0.3768 REMARK 3 T33: 0.3368 T12: -0.0061 REMARK 3 T13: -0.0087 T23: 0.0011 REMARK 3 L TENSOR REMARK 3 L11: 1.4290 L22: 5.0520 REMARK 3 L33: 2.8914 L12: -1.2651 REMARK 3 L13: -0.3745 L23: 1.5976 REMARK 3 S TENSOR REMARK 3 S11: 0.0224 S12: -0.2920 S13: 0.0991 REMARK 3 S21: 1.1707 S22: 0.0208 S23: -0.0384 REMARK 3 S31: 0.4623 S32: 0.2774 S33: -0.0482 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 327 THROUGH 358 ) REMARK 3 ORIGIN FOR THE GROUP (A): -5.4145 -1.4308 7.4534 REMARK 3 T TENSOR REMARK 3 T11: 0.2814 T22: 0.3958 REMARK 3 T33: 0.5020 T12: -0.1181 REMARK 3 T13: 0.1220 T23: 0.0227 REMARK 3 L TENSOR REMARK 3 L11: 7.3564 L22: 8.8116 REMARK 3 L33: 9.2237 L12: 0.2290 REMARK 3 L13: 3.5523 L23: -0.8055 REMARK 3 S TENSOR REMARK 3 S11: -0.2654 S12: -0.0584 S13: 0.1631 REMARK 3 S21: -0.0777 S22: 0.0816 S23: -0.5257 REMARK 3 S31: -1.0575 S32: 0.7491 S33: 0.1787 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL BOND LENGTH RESTRAINTS WERE USED REMARK 3 FOR THE CYS-RU67 COVALENT BOND REMARK 4 REMARK 4 8PSW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292131617. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28485 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 49.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 11.80 REMARK 200 R MERGE (I) : 0.14900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.60800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: RHOMBOID REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG1000, 0.1M HEPES PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.73500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.61000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.69500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.61000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.73500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.69500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 ALA A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 ALA A 7 REMARK 465 GLY A 8 REMARK 465 ALA A 9 REMARK 465 GLY A 10 REMARK 465 ASP A 177 REMARK 465 HIS A 178 REMARK 465 ASP A 179 REMARK 465 HIS A 180 REMARK 465 THR A 181 REMARK 465 GLY A 182 REMARK 465 PHE A 183 REMARK 465 LEU A 184 REMARK 465 THR A 185 REMARK 465 GLU A 186 REMARK 465 ARG A 359 REMARK 465 SER A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 187 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 VAL A 188 CG1 CG2 REMARK 470 LYS A 330 CG CD CE NZ REMARK 470 PHE A 331 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A 332 CG OD1 OD2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 148 -3.50 76.63 REMARK 500 ASP A 149 37.06 -140.50 REMARK 500 ASP A 167 81.49 60.17 REMARK 500 ASP A 167 81.49 60.16 REMARK 500 ASP A 175 89.82 -162.19 REMARK 500 LYS A 203 -72.10 -57.32 REMARK 500 LEU A 294 52.29 -96.78 REMARK 500 ASP A 318 88.86 -153.15 REMARK 500 GLU A 334 72.35 57.27 REMARK 500 REMARK 500 REMARK: NULL DBREF 8PSW A 1 360 UNP P28482 MK01_HUMAN 1 360 SEQADV 8PSW GLY A -3 UNP P28482 EXPRESSION TAG SEQADV 8PSW SER A -2 UNP P28482 EXPRESSION TAG SEQADV 8PSW ALA A -1 UNP P28482 EXPRESSION TAG SEQADV 8PSW SER A 0 UNP P28482 EXPRESSION TAG SEQRES 1 A 364 GLY SER ALA SER MET ALA ALA ALA ALA ALA ALA GLY ALA SEQRES 2 A 364 GLY PRO GLU MET VAL ARG GLY GLN VAL PHE ASP VAL GLY SEQRES 3 A 364 PRO ARG TYR THR ASN LEU SER TYR ILE GLY GLU GLY ALA SEQRES 4 A 364 TYR GLY MET VAL CYS SER ALA TYR ASP ASN VAL ASN LYS SEQRES 5 A 364 VAL ARG VAL ALA ILE LYS LYS ILE SER PRO PHE GLU HIS SEQRES 6 A 364 GLN THR TYR CYS GLN ARG THR LEU ARG GLU ILE LYS ILE SEQRES 7 A 364 LEU LEU ARG PHE ARG HIS GLU ASN ILE ILE GLY ILE ASN SEQRES 8 A 364 ASP ILE ILE ARG ALA PRO THR ILE GLU GLN MET LYS ASP SEQRES 9 A 364 VAL TYR ILE VAL GLN ASP LEU MET GLU THR ASP LEU TYR SEQRES 10 A 364 LYS LEU LEU LYS THR GLN HIS LEU SER ASN ASP HIS ILE SEQRES 11 A 364 CYS TYR PHE LEU TYR GLN ILE LEU ARG GLY LEU LYS TYR SEQRES 12 A 364 ILE HIS SER ALA ASN VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 13 A 364 SER ASN LEU LEU LEU ASN THR THR CYS ASP LEU LYS ILE SEQRES 14 A 364 CYS ASP PHE GLY LEU ALA ARG VAL ALA ASP PRO ASP HIS SEQRES 15 A 364 ASP HIS THR GLY PHE LEU THR GLU TYR VAL ALA THR ARG SEQRES 16 A 364 TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SER LYS GLY SEQRES 17 A 364 TYR THR LYS SER ILE ASP ILE TRP SER VAL GLY CYS ILE SEQRES 18 A 364 LEU ALA GLU MET LEU SER ASN ARG PRO ILE PHE PRO GLY SEQRES 19 A 364 LYS HIS TYR LEU ASP GLN LEU ASN HIS ILE LEU GLY ILE SEQRES 20 A 364 LEU GLY SER PRO SER GLN GLU ASP LEU ASN CYS ILE ILE SEQRES 21 A 364 ASN LEU LYS ALA ARG ASN TYR LEU LEU SER LEU PRO HIS SEQRES 22 A 364 LYS ASN LYS VAL PRO TRP ASN ARG LEU PHE PRO ASN ALA SEQRES 23 A 364 ASP SER LYS ALA LEU ASP LEU LEU ASP LYS MET LEU THR SEQRES 24 A 364 PHE ASN PRO HIS LYS ARG ILE GLU VAL GLU GLN ALA LEU SEQRES 25 A 364 ALA HIS PRO TYR LEU GLU GLN TYR TYR ASP PRO SER ASP SEQRES 26 A 364 GLU PRO ILE ALA GLU ALA PRO PHE LYS PHE ASP MET GLU SEQRES 27 A 364 LEU ASP ASP LEU PRO LYS GLU LYS LEU LYS GLU LEU ILE SEQRES 28 A 364 PHE GLU GLU THR ALA ARG PHE GLN PRO GLY TYR ARG SER HET AN2 A 401 27 HET D2I A 402 25 HETNAM AN2 AMP PHOSPHORAMIDATE HETNAM D2I ~{O}3-~{TERT}-BUTYL ~{O}1-METHYL (1~{R},3~{R})-4- HETNAM 2 D2I OXIDANYLIDENE-1-(PHENYLMETHYL)CYCLOHEXANE-1,3- HETNAM 3 D2I DICARBOXYLATE FORMUL 2 AN2 C10 H16 N6 O9 P2 FORMUL 3 D2I C20 H26 O5 FORMUL 4 HOH *105(H2 O) HELIX 1 AA1 HIS A 61 PHE A 78 1 18 HELIX 2 AA2 THR A 94 MET A 98 5 5 HELIX 3 AA3 LEU A 112 LYS A 117 1 6 HELIX 4 AA4 SER A 122 ALA A 143 1 22 HELIX 5 AA5 LYS A 151 SER A 153 5 3 HELIX 6 AA6 ALA A 195 LEU A 200 1 6 HELIX 7 AA7 LYS A 207 ASN A 224 1 18 HELIX 8 AA8 HIS A 232 GLY A 245 1 14 HELIX 9 AA9 SER A 248 ASN A 253 1 6 HELIX 10 AB1 ASN A 257 SER A 266 1 10 HELIX 11 AB2 PRO A 274 PHE A 279 1 6 HELIX 12 AB3 ASP A 283 LEU A 294 1 12 HELIX 13 AB4 GLU A 303 ALA A 309 1 7 HELIX 14 AB5 HIS A 310 GLU A 314 5 5 HELIX 15 AB6 ASP A 318 GLU A 322 5 5 HELIX 16 AB7 PRO A 339 THR A 351 1 13 HELIX 17 AB8 ALA A 352 GLN A 355 5 4 SHEET 1 AA1 2 MET A 13 VAL A 14 0 SHEET 2 AA1 2 GLN A 17 VAL A 18 -1 O GLN A 17 N VAL A 14 SHEET 1 AA2 5 TYR A 25 GLU A 33 0 SHEET 2 AA2 5 GLY A 37 ASP A 44 -1 O VAL A 39 N GLY A 32 SHEET 3 AA2 5 VAL A 49 ILE A 56 -1 O LYS A 55 N MET A 38 SHEET 4 AA2 5 VAL A 101 ASP A 106 -1 O GLN A 105 N ALA A 52 SHEET 5 AA2 5 ILE A 86 ILE A 90 -1 N ASN A 87 O VAL A 104 SHEET 1 AA3 3 THR A 110 ASP A 111 0 SHEET 2 AA3 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 AA3 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 AA4 2 VAL A 145 LEU A 146 0 SHEET 2 AA4 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 LINK SG CYS A 161 C3 D2I A 402 1555 1555 1.73 CISPEP 1 GLY A 22 PRO A 23 0 -2.08 CRYST1 41.470 77.390 127.220 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024114 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012922 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007860 0.00000